Table 2.
Variables | N (%) | Median |
---|---|---|
In-hospital stay (days) | - | 10 (6–41) |
Histopathological entity | ||
malignant | 71 (61.7%) | |
benign | 44 (38.3%) | |
UICC classification | ||
Stage 0 (after neoadjuvant therapy) | 8 (7.0%) | |
Stage I | 20 (17.4%) | |
Stage II | 24 (20.9%) | |
Stage III | 16 (13.9%) | |
Stage IV | 3 (2.6%) | |
Clavien-Dindo classification (CDC) | ||
Grade IIIa | 5 (4.3%) | |
Grade IIIb | 2 (1.7%) | |
Grade IV | 1 (0.9%) | |
Anastomotic leakage | 8 (6.9%) |